1. An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect. Issue 1 (1st March 2022) Authors: Rahal, Farah; Capdevielle, Caroline; Rousseau, Benoit; Izotte, Julien; Dupuy, Jean-William; Cappellen, David; Chotard, Guillaume; Ménard, Mélissa; Charpentier, Justine; Jecko, Vincent; Caumont, Charline; Gimbert, Edouard; Grosset, Christophe F; Hagedorn, Martin Journal: Neuro-oncology advances Issue: Volume 4:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗